Cargando…
The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice
Cachexia, or muscle-wasting syndrome, is one of the major causes of death in patients affected by diseases such as cancer, AIDS and sepsis. However, no effective anti-cachectic treatment is currently available. Here we show that a low dose of pateamine A, an inhibitor of translation initiation, prev...
Autores principales: | Di Marco, Sergio, Cammas, Anne, Lian, Xian Jin, Kovacs, Erzsebet Nagy, Ma, Jennifer F., Hall, Derek T., Mazroui, Rachid, Richardson, John, Pelletier, Jerry, Gallouzi, Imed Eddine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621420/ https://www.ncbi.nlm.nih.gov/pubmed/22692539 http://dx.doi.org/10.1038/ncomms1899 |
Ejemplares similares
-
Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia
por: Hall, Derek T., et al.
Publicado: (2011) -
Pharmacological or genetic inhibition of iNOS prevents cachexia‐mediated muscle wasting and its associated metabolism defects
por: Sadek, Jason, et al.
Publicado: (2021) -
eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways
por: Cramer, Zvi, et al.
Publicado: (2018) -
Pateamine A-sensitive ribosome profiling reveals the scope of translation in mouse embryonic stem cells
por: Popa, Alexandra, et al.
Publicado: (2016) -
Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis
por: Mazroui, Rachid, et al.
Publicado: (2008)